A new HIV-prevention drug is showing promising signs
Prep can make HIV harder to detect if an infection occurs. Clear donation guidance can help protect donors and people ...
A study that reviewed New York State data shows that HIV seldom passes from parent to infant, though an unsuppressed viral ...
The drug is expected to cost $40 a year per person in the countries where it will be available, the same price as daily ...
A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up, ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...
In people living with HIV, each additional year of integrase inhibitor use is associated with higher odds of severe liver ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the ...
AllAfrica on MSN
HIV - Lagos Survey Reveals Treatment Gains, Testing Gap
... Women record twice men's prevalence as state targets wider coverageLagos State has recorded significant progress in HIV treatment, with 93.4 per cent of people living with the virus who know their ...
2don MSN
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results